glutathione and triple negative breast cancer

glutathione and triple negative breast cancer Ratiometrically designed nanoprodrug for triple-negative treatment Glutathione depletion and dihydroorotate dehydrogenase

Name: glutathione and triple negative breast cancer Ratiometrically designed nanoprodrug for triple-negative treatment Glutathione depletion and dihydroorotate dehydrogenase
Brand: dynamiccapital.ca
SKU: 36908835808
Price: 28.00 USD
Availability: InStock
Rating: 4.1818 (15 reviews)

Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect GSTP1 Is a Driver of Triple Negative Breast Cancer Cell Metabolism and Pathogenicity ScienceDirect Involvement of glutathione peroxidases in the occurrence and development of breast cancers Journal of Translational Medicine Springer Nature Link

SKU: 36908835808 · From dynamiccapital.ca

4.2

USD28.00 USD53.00

Pay in 4 interest-free payments of $7.00 Learn more